-
26 Oct 2026
Treatment Approach to Major Depressive Disorder
The Journal of the American Medical Association
- Views 38
- More stats
-
26 Oct 2026
Orforglipron for Type 2 Diabetes and Pancreatic Risk Assessment
The Journal of the American Medical Association
- Views 29
- More stats
-
26 Oct 2026
Orforglipron for Type 2 Diabetes and Pancreatic Risk Assessment—Reply
The Journal of the American Medical Association
- Views 29
- More stats
-
26 Oct 2026
Single Intranasal Administration of the Psychedelic Mebufotenin for Treatment-Resistant Depression
The Journal of the American Medical Association
- Views 37
- More stats
-
26 Oct 2026
Patient Information: Medications for Alcohol Use Disorder
The Journal of the American Medical Association
- Views 29
- More stats
-
26 Oct 2026
Single Intranasal Administration of the Psychedelic Mebufotenin for Treatment-Resistant Depression Research Summary
The Journal of the American Medical Association
- Views 46
- More stats
-
26 Oct 2026
Peptides, FDA’s Pharmacy Compounding Advisory Committee, and the Future of FDA Drug Approval
The Journal of the American Medical Association
- Views 40
- More stats
-
26 Oct 2026
A microbiome-reactive TMIGD2hi Th17 subset is spatially enriched at the intestinal epithelium and expanded in inflammatory bowel disease
Immunity
- Views 37
- More stats
-
26 Oct 2026
Human brain cellular xenografts in neuroimmunology and beyond
Immunity
- Views 25
- More stats
-
26 Oct 2026
Publisher Correction: Phenomic profiles and disease patterns of 1.9 million participants from Our Future Health
Nature Medicine
- Views 34
- More stats
Journal Content
Life Science Network features journal content imported from some of the most popular scientific journals. In addition, the Publications module allows you to import or add your own publications to our database. Note that the indicated journal impact factors are not regularly updated.
Check the Publications module here
Advertisement